Proteus mirabilis resistant to expanded-spectrum cephalsoporins (ESC) is an emerging problem. In addition to extended-sectrum -lactamases (ESBLs), acquired AmpC-type -lactamases represent an important mechanism of resistance to ESC in P. mirabilis, at least in some countries. Distinction of clinical isolates producing an ESBL or an AmpC-type enzyme is a matter of interest for the implications in surveillance, infection control, and treatment issues. This work describes a simple and practical Double Synergy Differential Test (DSDT) that couples the detection of ESBLs and AmpC-type enzymes by means of a combo-disk approach using cefotaxime and ceftazidime as indicator substrates, and clavulanate and boronic acid as enzyme inhibitors. The DSDT was tested with a collection of 104 P. mirabilis with different beta-lactamase profiles, and proved to be highly sensitive and specific for the detection of ESBL- and AmpC-producing isolates.

Double Synergy Differential Test for detection of plasmid-mediated AmpC-type beta-lactamases in Proteus mirabilis / Sabia, Carla; M., Sarti; E., Mantengoli; R., Gargiulo; C., Mugnaioli; G. M., Rossolini. - In: JOURNAL OF MEDICAL MICROBIOLOGY. - ISSN 0022-2615. - ELETTRONICO. - 59(2010), pp. 998-1000.

I documenti presenti in Iris Unimore sono rilasciati con licenza Creative Commons Attribuzione - Non commerciale - Non opere derivate 3.0 Italia, salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Powered by IRIS-about IRIS-Utilizzo dei cookie

 Copyright © 2021